379 related articles for article (PubMed ID: 9107077)
1. Peripheral blood picture in primary hypocellular refractory anemia and idiopathic acquired aplastic anemia: an additional tool for differential diagnosis.
Elghetany MT; Hudnall SD; Gardner FH
Haematologica; 1997; 82(1):21-4. PubMed ID: 9107077
[TBL] [Abstract][Full Text] [Related]
2. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
3. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
[TBL] [Abstract][Full Text] [Related]
4. Clinical and cytogenetic findings of myelodysplastic syndromes showing hypocellular bone marrow or minimal dysplasia, in comparison with typical myelodysplastic syndromes.
Toyama K; Ohyashiki K; Yoshida Y; Abe T; Asano S; Hirai H; Hirashima K; Hotta T; Kuramoto A; Kuriya S
Int J Hematol; 1993 Aug; 58(1-2):53-61. PubMed ID: 8219112
[TBL] [Abstract][Full Text] [Related]
5. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
[TBL] [Abstract][Full Text] [Related]
6. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
7. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
[TBL] [Abstract][Full Text] [Related]
8. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of femoral marrow cellularity in hypocellular haemopoietic disorders.
Lorand-Metze I; Santiago GF; Lima CS; Zanardi VA; Torriani M
Clin Radiol; 2001 Feb; 56(2):107-10. PubMed ID: 11222066
[TBL] [Abstract][Full Text] [Related]
10. [A study of hypoplastic myelodysplastic syndrome].
Sato Y; Mituhashi S; Otani K; Kamoshita M; Hasegawa Y; Ninomiya H; Nagasawa T; Abe T
Rinsho Ketsueki; 1993 Nov; 34(11):1431-7. PubMed ID: 8254904
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric evaluation of circulating CD34+ cell counts and apoptotic rate in children with acquired aplastic anemia and myelodysplasia.
Timeus F; Crescenzio N; Doria A; Foglia L; Linari A; Giaccone M; Pastore G; di Montezemolo LC; Ramenghi U; Saracco P
Exp Hematol; 2005 May; 33(5):597-604. PubMed ID: 15850838
[TBL] [Abstract][Full Text] [Related]
12. A cohort study of the nature of paroxysmal nocturnal hemoglobinuria clones and PIG-A mutations in patients with aplastic anemia.
Wanachiwanawin W; Siripanyaphinyo U; Piyawattanasakul N; Kinoshita T
Eur J Haematol; 2006 Jun; 76(6):502-9. PubMed ID: 16529603
[TBL] [Abstract][Full Text] [Related]
13. A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia.
Nimer SD; Paquette RL; Ireland P; Resta D; Young D; Golde DW
Exp Hematol; 1994 Aug; 22(9):875-80. PubMed ID: 8062886
[TBL] [Abstract][Full Text] [Related]
14. [Hematological characteristics of hypoplastic MDS patients with chromosomal abnormalities, who had been followed for aplastic anemia with normal karyotypes].
Tamai Y; Takami H; Nakahata R; Nakui Y; Suzuki Y; Akagi T; Kariya K; Tsushima K; Munakata A; Kawamura S
Rinsho Ketsueki; 1997 Dec; 38(12):1243-8. PubMed ID: 9455142
[TBL] [Abstract][Full Text] [Related]
15. Aplastic anemia with circulating erythroblasts.
Yokose N; Ogata K; Dan K; Nomura T
Int J Hematol; 1994 Aug; 60(2):111-7. PubMed ID: 7948960
[TBL] [Abstract][Full Text] [Related]
16. [Histopathologic characteristics of bone marrow in patients with aplastic anemia].
Milosević R; Janković G; Antonijević N; Jovanović V; Babić D; Colović M
Srp Arh Celok Lek; 2000; 128(5-6):200-4. PubMed ID: 11089422
[TBL] [Abstract][Full Text] [Related]
17. Soluble transferrin receptor and its ratio to erythroblasts in bone marrow may be a new diagnostic tool to distinguish between aplastic and refractory anemia.
Matsuda A; Misumi M; Shimada T; Yoshida K; Yagasaki F; Ito Y; Kawai N; Murohashi I; Hirashima K; Bessho M
Acta Haematol; 2004; 111(3):138-42. PubMed ID: 15034234
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
19. [Magnetic resonance imaging of the bone marrow in patients with aplastic anemia and myelodysplastic syndrome].
Kusumoto S
Rinsho Ketsueki; 1992 Apr; 33(4):423-9. PubMed ID: 1602604
[TBL] [Abstract][Full Text] [Related]
20. Acquired aplastic anemia.
Keohane EM
Clin Lab Sci; 2004; 17(3):165-71. PubMed ID: 15314891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
